Invezz

Is Senseonics a good investment ahead of joining the Russel 3000 Index?

Is Senseonics a good investment ahead of joining the Russel 3000 Index?
Motiur Rahman
Jun 25, 2021, 18:38 PM
  • Senseonics stock price popped 5.28% on Friday.
  • The company joins Clovis Oncology among the latest additions to the Russel 3000 Index.
  • SENS stock is up more than 307% this year and 824% over the previous 12 months. Time to buy?

Senseonics Holdings Inc. (NYSEAMERICAN:SENS) shares bounced back 5.28% on Friday, more than 10% this week, after falling nearly 20% last week. The stock is now up more than 307% this year and 824% in the 12 months. Its addition to the Russel 3000 Index will attract institutional investors and fund managers. 

Fundamentals overview: Senseonics has exciting growth

Senseonics’ gains during the last four years could imply overvaluation. However, analysts expect earnings to grow by 79% this year, making it an exciting growth story.

The bottom line will also grow at an average of about 29% in each of the next five years. Therefore, the company will be attractive to growth investors. 

Technical overview: the rebound has momentum

Technically, SENS shares appear to have bounced back this week after last week’s plunge. However, the bullish movement seems to have momentum moving closer to overbought conditions.

Investors can target extended rebounds at $4.37 and $4.96. The key support levels are $3.38 and $2.86.

Bottom line: the rebound seems set to continue

In summary, Senseonics shares seem to enjoy a strong run after this week’s rebound. As a result, investors can look to ride the current recovery ahead of the company’s exciting growth story.